nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.00863	0.0378	CcSEcCtD
Phenazopyridine—Visual disturbance—Tamoxifen—pancreatic cancer	0.00831	0.0364	CcSEcCtD
Phenazopyridine—Visual disturbance—Irinotecan—pancreatic cancer	0.00587	0.0257	CcSEcCtD
Phenazopyridine—Hepatitis—Tamoxifen—pancreatic cancer	0.00545	0.0239	CcSEcCtD
Phenazopyridine—Hepatitis—Erlotinib—pancreatic cancer	0.00539	0.0236	CcSEcCtD
Phenazopyridine—Visual impairment—Tamoxifen—pancreatic cancer	0.00525	0.023	CcSEcCtD
Phenazopyridine—Hepatitis—Sunitinib—pancreatic cancer	0.00467	0.0204	CcSEcCtD
Phenazopyridine—Jaundice—Irinotecan—pancreatic cancer	0.00418	0.0183	CcSEcCtD
Phenazopyridine—Visual disturbance—Docetaxel—pancreatic cancer	0.00405	0.0178	CcSEcCtD
Phenazopyridine—Visual impairment—Irinotecan—pancreatic cancer	0.00371	0.0162	CcSEcCtD
Phenazopyridine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00341	0.0149	CcSEcCtD
Phenazopyridine—Dyspepsia—Erlotinib—pancreatic cancer	0.00337	0.0148	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00334	0.0146	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00331	0.0145	CcSEcCtD
Phenazopyridine—Dyspepsia—Sunitinib—pancreatic cancer	0.00292	0.0128	CcSEcCtD
Phenazopyridine—Jaundice—Docetaxel—pancreatic cancer	0.00289	0.0126	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00286	0.0125	CcSEcCtD
Phenazopyridine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00285	0.0125	CcSEcCtD
Phenazopyridine—Pruritus—Tamoxifen—pancreatic cancer	0.00274	0.012	CcSEcCtD
Phenazopyridine—Pruritus—Erlotinib—pancreatic cancer	0.00271	0.0119	CcSEcCtD
Phenazopyridine—Hepatitis—Docetaxel—pancreatic cancer	0.00266	0.0116	CcSEcCtD
Phenazopyridine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00265	0.0116	CcSEcCtD
Phenazopyridine—Diarrhoea—Erlotinib—pancreatic cancer	0.00262	0.0115	CcSEcCtD
Phenazopyridine—Visual impairment—Docetaxel—pancreatic cancer	0.00256	0.0112	CcSEcCtD
Phenazopyridine—Vomiting—Tamoxifen—pancreatic cancer	0.00246	0.0108	CcSEcCtD
Phenazopyridine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00244	0.0107	CcSEcCtD
Phenazopyridine—Rash—Tamoxifen—pancreatic cancer	0.00244	0.0107	CcSEcCtD
Phenazopyridine—Dermatitis—Tamoxifen—pancreatic cancer	0.00244	0.0107	CcSEcCtD
Phenazopyridine—Vomiting—Erlotinib—pancreatic cancer	0.00244	0.0107	CcSEcCtD
Phenazopyridine—Headache—Tamoxifen—pancreatic cancer	0.00243	0.0106	CcSEcCtD
Phenazopyridine—Rash—Erlotinib—pancreatic cancer	0.00242	0.0106	CcSEcCtD
Phenazopyridine—Dermatitis—Erlotinib—pancreatic cancer	0.00241	0.0106	CcSEcCtD
Phenazopyridine—Dyspepsia—Irinotecan—pancreatic cancer	0.0024	0.0105	CcSEcCtD
Phenazopyridine—Headache—Erlotinib—pancreatic cancer	0.0024	0.0105	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00236	0.0103	CcSEcCtD
Phenazopyridine—Pruritus—Sunitinib—pancreatic cancer	0.00235	0.0103	CcSEcCtD
Phenazopyridine—Dyspepsia—Fluorouracil—pancreatic cancer	0.0023	0.0101	CcSEcCtD
Phenazopyridine—Nausea—Tamoxifen—pancreatic cancer	0.0023	0.0101	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0023	0.0101	CcSEcCtD
Phenazopyridine—Nausea—Erlotinib—pancreatic cancer	0.00228	0.00996	CcSEcCtD
Phenazopyridine—Diarrhoea—Sunitinib—pancreatic cancer	0.00227	0.00993	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00226	0.00989	CcSEcCtD
Phenazopyridine—Vomiting—Sunitinib—pancreatic cancer	0.00211	0.00923	CcSEcCtD
Phenazopyridine—Rash—Sunitinib—pancreatic cancer	0.00209	0.00916	CcSEcCtD
Phenazopyridine—Dermatitis—Sunitinib—pancreatic cancer	0.00209	0.00915	CcSEcCtD
Phenazopyridine—Headache—Sunitinib—pancreatic cancer	0.00208	0.0091	CcSEcCtD
Phenazopyridine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00201	0.00881	CcSEcCtD
Phenazopyridine—Nausea—Sunitinib—pancreatic cancer	0.00197	0.00862	CcSEcCtD
Phenazopyridine—Jaundice—Epirubicin—pancreatic cancer	0.00195	0.00852	CcSEcCtD
Phenazopyridine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00193	0.00844	CcSEcCtD
Phenazopyridine—Pruritus—Gemcitabine—pancreatic cancer	0.00188	0.00824	CcSEcCtD
Phenazopyridine—Diarrhoea—Irinotecan—pancreatic cancer	0.00187	0.00818	CcSEcCtD
Phenazopyridine—Pruritus—Fluorouracil—pancreatic cancer	0.00185	0.0081	CcSEcCtD
Phenazopyridine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00182	0.00797	CcSEcCtD
Phenazopyridine—Jaundice—Doxorubicin—pancreatic cancer	0.0018	0.00789	CcSEcCtD
Phenazopyridine—Hepatitis—Epirubicin—pancreatic cancer	0.00179	0.00785	CcSEcCtD
Phenazopyridine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00179	0.00784	CcSEcCtD
Phenazopyridine—Vomiting—Irinotecan—pancreatic cancer	0.00174	0.0076	CcSEcCtD
Phenazopyridine—Visual impairment—Epirubicin—pancreatic cancer	0.00173	0.00756	CcSEcCtD
Phenazopyridine—Rash—Irinotecan—pancreatic cancer	0.00172	0.00754	CcSEcCtD
Phenazopyridine—Dermatitis—Irinotecan—pancreatic cancer	0.00172	0.00753	CcSEcCtD
Phenazopyridine—Headache—Irinotecan—pancreatic cancer	0.00171	0.00749	CcSEcCtD
Phenazopyridine—Vomiting—Gemcitabine—pancreatic cancer	0.00169	0.00741	CcSEcCtD
Phenazopyridine—Rash—Gemcitabine—pancreatic cancer	0.00168	0.00735	CcSEcCtD
Phenazopyridine—Dermatitis—Gemcitabine—pancreatic cancer	0.00168	0.00734	CcSEcCtD
Phenazopyridine—Headache—Gemcitabine—pancreatic cancer	0.00167	0.0073	CcSEcCtD
Phenazopyridine—Vomiting—Fluorouracil—pancreatic cancer	0.00166	0.00728	CcSEcCtD
Phenazopyridine—Dyspepsia—Docetaxel—pancreatic cancer	0.00166	0.00728	CcSEcCtD
Phenazopyridine—Hepatitis—Doxorubicin—pancreatic cancer	0.00166	0.00726	CcSEcCtD
Phenazopyridine—Rash—Fluorouracil—pancreatic cancer	0.00165	0.00722	CcSEcCtD
Phenazopyridine—Dermatitis—Fluorouracil—pancreatic cancer	0.00165	0.00722	CcSEcCtD
Phenazopyridine—Headache—Fluorouracil—pancreatic cancer	0.00164	0.00718	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00163	0.00714	CcSEcCtD
Phenazopyridine—Nausea—Irinotecan—pancreatic cancer	0.00162	0.0071	CcSEcCtD
Phenazopyridine—Visual impairment—Doxorubicin—pancreatic cancer	0.0016	0.007	CcSEcCtD
Phenazopyridine—Nausea—Gemcitabine—pancreatic cancer	0.00158	0.00692	CcSEcCtD
Phenazopyridine—Nausea—Fluorouracil—pancreatic cancer	0.00155	0.0068	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—VEGFA—pancreatic cancer	0.00145	0.00187	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NOTCH1—pancreatic cancer	0.00144	0.00186	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—MMP9—pancreatic cancer	0.00143	0.00186	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—NRAS—pancreatic cancer	0.00143	0.00185	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HES1—pancreatic cancer	0.00142	0.00183	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HES1—pancreatic cancer	0.00142	0.00183	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—EGFR—pancreatic cancer	0.00141	0.00183	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MMP2—pancreatic cancer	0.00141	0.00183	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SMAD4—pancreatic cancer	0.0014	0.00181	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SMAD4—pancreatic cancer	0.0014	0.00181	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00139	0.00609	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—HES1—pancreatic cancer	0.00136	0.00177	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HES1—pancreatic cancer	0.00136	0.00177	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP2—pancreatic cancer	0.00136	0.00177	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PPARG—pancreatic cancer	0.00136	0.00176	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MMP2—pancreatic cancer	0.00135	0.00175	CbGpPWpGaD
Phenazopyridine—Pruritus—Docetaxel—pancreatic cancer	0.00134	0.00585	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—SRC—pancreatic cancer	0.00132	0.00171	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MMP9—pancreatic cancer	0.00131	0.0017	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.00131	0.0017	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—EGFR—pancreatic cancer	0.0013	0.00169	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP2—pancreatic cancer	0.0013	0.00168	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP2—pancreatic cancer	0.0013	0.00168	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Docetaxel—pancreatic cancer	0.00129	0.00566	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—VEGFA—pancreatic cancer	0.00129	0.00167	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—NRAS—pancreatic cancer	0.00127	0.00165	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00126	0.00163	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MMP2—pancreatic cancer	0.00125	0.00162	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP2—pancreatic cancer	0.00125	0.00162	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MMP2—pancreatic cancer	0.00125	0.00161	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KDR—pancreatic cancer	0.00123	0.0016	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—KRAS—pancreatic cancer	0.00123	0.00159	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.00121	0.00157	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—SRC—pancreatic cancer	0.00121	0.00157	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MET—pancreatic cancer	0.00121	0.00157	CbGpPWpGaD
Phenazopyridine—Vomiting—Docetaxel—pancreatic cancer	0.0012	0.00526	CcSEcCtD
Phenazopyridine—Rash—Docetaxel—pancreatic cancer	0.00119	0.00521	CcSEcCtD
Phenazopyridine—Dermatitis—Docetaxel—pancreatic cancer	0.00119	0.00521	CcSEcCtD
Phenazopyridine—Headache—Docetaxel—pancreatic cancer	0.00118	0.00518	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—KDR—pancreatic cancer	0.00118	0.00153	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—VEGFA—pancreatic cancer	0.00118	0.00153	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—CTNNB1—pancreatic cancer	0.00117	0.00152	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—NRAS—pancreatic cancer	0.00116	0.00151	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NOTCH1—pancreatic cancer	0.00116	0.00151	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—EGFR—pancreatic cancer	0.00116	0.0015	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MET—pancreatic cancer	0.00116	0.0015	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MMP9—pancreatic cancer	0.00115	0.00149	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KDR—pancreatic cancer	0.00113	0.00147	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KDR—pancreatic cancer	0.00113	0.00147	CbGpPWpGaD
Phenazopyridine—Nausea—Docetaxel—pancreatic cancer	0.00112	0.00491	CcSEcCtD
Phenazopyridine—Dyspepsia—Epirubicin—pancreatic cancer	0.00112	0.00491	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—NOTCH1—pancreatic cancer	0.00111	0.00144	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MET—pancreatic cancer	0.00111	0.00144	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MET—pancreatic cancer	0.00111	0.00144	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.0011	0.00481	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—PPARG—pancreatic cancer	0.0011	0.00142	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—KRAS—pancreatic cancer	0.0011	0.00142	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KDR—pancreatic cancer	0.00109	0.00142	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KDR—pancreatic cancer	0.00109	0.00142	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KDR—pancreatic cancer	0.00108	0.0014	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MET—pancreatic cancer	0.00107	0.00139	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MET—pancreatic cancer	0.00107	0.00139	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NOTCH1—pancreatic cancer	0.00107	0.00138	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NOTCH1—pancreatic cancer	0.00107	0.00138	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.00107	0.00138	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MMP9—pancreatic cancer	0.00106	0.00138	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—EGFR—pancreatic cancer	0.00106	0.00137	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SRC—pancreatic cancer	0.00106	0.00137	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MET—pancreatic cancer	0.00105	0.00137	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PPARG—pancreatic cancer	0.00105	0.00136	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—HRAS—pancreatic cancer	0.00104	0.00135	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CTNNB1—pancreatic cancer	0.00104	0.00135	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Doxorubicin—pancreatic cancer	0.00104	0.00454	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—pancreatic cancer	0.00103	0.00134	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NOTCH1—pancreatic cancer	0.00103	0.00134	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NOTCH1—pancreatic cancer	0.00103	0.00134	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP9—pancreatic cancer	0.00102	0.00133	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—STAT3—pancreatic cancer	0.00102	0.00132	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—NRAS—pancreatic cancer	0.00102	0.00132	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00102	0.00445	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—MMP9—pancreatic cancer	0.00101	0.00132	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PPARG—pancreatic cancer	0.00101	0.00131	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PPARG—pancreatic cancer	0.00101	0.00131	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP2—pancreatic cancer	0.00101	0.00131	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—KRAS—pancreatic cancer	0.001	0.0013	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SMAD4—pancreatic cancer	0.000983	0.00127	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SRC—pancreatic cancer	0.000978	0.00127	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP9—pancreatic cancer	0.000975	0.00126	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP9—pancreatic cancer	0.000975	0.00126	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PPARG—pancreatic cancer	0.000972	0.00126	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PPARG—pancreatic cancer	0.000972	0.00126	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP2—pancreatic cancer	0.000964	0.00125	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HES1—pancreatic cancer	0.000959	0.00124	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CTNNB1—pancreatic cancer	0.000955	0.00124	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—pancreatic cancer	0.000953	0.00123	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TGFB1—pancreatic cancer	0.000947	0.00123	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SRC—pancreatic cancer	0.000944	0.00122	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—NRAS—pancreatic cancer	0.000941	0.00122	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MMP9—pancreatic cancer	0.00094	0.00122	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP9—pancreatic cancer	0.00094	0.00122	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000938	0.00411	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—MMP9—pancreatic cancer	0.000936	0.00121	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SRC—pancreatic cancer	0.000936	0.00121	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—HRAS—pancreatic cancer	0.000931	0.00121	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—EGFR—pancreatic cancer	0.000928	0.0012	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP2—pancreatic cancer	0.000926	0.0012	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP2—pancreatic cancer	0.000926	0.0012	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—pancreatic cancer	0.000919	0.00119	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000913	0.00118	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—pancreatic cancer	0.000911	0.00118	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—STAT3—pancreatic cancer	0.00091	0.00118	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—NRAS—pancreatic cancer	0.000908	0.00118	CbGpPWpGaD
Phenazopyridine—Pruritus—Epirubicin—pancreatic cancer	0.000901	0.00395	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—NRAS—pancreatic cancer	0.0009	0.00117	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SRC—pancreatic cancer	0.000899	0.00117	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SRC—pancreatic cancer	0.000899	0.00117	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP2—pancreatic cancer	0.000893	0.00116	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP2—pancreatic cancer	0.000893	0.00116	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—pancreatic cancer	0.000884	0.00115	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP2—pancreatic cancer	0.000879	0.00114	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KRAS—pancreatic cancer	0.000877	0.00114	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—pancreatic cancer	0.000876	0.00113	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—pancreatic cancer	0.000876	0.00113	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Epirubicin—pancreatic cancer	0.000872	0.00382	CcSEcCtD
Phenazopyridine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000868	0.0038	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—SRC—pancreatic cancer	0.000867	0.00112	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SRC—pancreatic cancer	0.000867	0.00112	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—NRAS—pancreatic cancer	0.000865	0.00112	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—NRAS—pancreatic cancer	0.000865	0.00112	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SRC—pancreatic cancer	0.000863	0.00112	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—EGFR—pancreatic cancer	0.000857	0.00111	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—HRAS—pancreatic cancer	0.000851	0.0011	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—pancreatic cancer	0.000844	0.00109	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—pancreatic cancer	0.000844	0.00109	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TGFB1—pancreatic cancer	0.000844	0.00109	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—pancreatic cancer	0.000841	0.00109	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—NRAS—pancreatic cancer	0.000834	0.00108	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—NRAS—pancreatic cancer	0.000834	0.00108	CbGpPWpGaD
Phenazopyridine—Pruritus—Doxorubicin—pancreatic cancer	0.000834	0.00365	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—STAT3—pancreatic cancer	0.000832	0.00108	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NRAS—pancreatic cancer	0.00083	0.00108	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EGFR—pancreatic cancer	0.000827	0.00107	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—EGFR—pancreatic cancer	0.00082	0.00106	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KRAS—pancreatic cancer	0.00081	0.00105	CbGpPWpGaD
Phenazopyridine—Vomiting—Epirubicin—pancreatic cancer	0.00081	0.00355	CcSEcCtD
Phenazopyridine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000806	0.00353	CcSEcCtD
Phenazopyridine—Rash—Epirubicin—pancreatic cancer	0.000803	0.00352	CcSEcCtD
Phenazopyridine—Dermatitis—Epirubicin—pancreatic cancer	0.000802	0.00351	CcSEcCtD
Phenazopyridine—Headache—Epirubicin—pancreatic cancer	0.000798	0.00349	CcSEcCtD
Phenazopyridine—SCN2A—Axon guidance—EGFR—pancreatic cancer	0.000788	0.00102	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—EGFR—pancreatic cancer	0.000788	0.00102	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—pancreatic cancer	0.000788	0.00102	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KRAS—pancreatic cancer	0.000781	0.00101	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KRAS—pancreatic cancer	0.000775	0.001	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CTNNB1—pancreatic cancer	0.000772	0.001	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TGFB1—pancreatic cancer	0.000772	0.001	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KDR—pancreatic cancer	0.000769	0.000996	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—EGFR—pancreatic cancer	0.00076	0.000985	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—EGFR—pancreatic cancer	0.00076	0.000985	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP9—pancreatic cancer	0.000757	0.000981	CbGpPWpGaD
Phenazopyridine—Nausea—Epirubicin—pancreatic cancer	0.000757	0.00331	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—EGFR—pancreatic cancer	0.000757	0.000981	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MET—pancreatic cancer	0.000752	0.000975	CbGpPWpGaD
Phenazopyridine—Vomiting—Doxorubicin—pancreatic cancer	0.000749	0.00328	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—HRAS—pancreatic cancer	0.000745	0.000966	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KRAS—pancreatic cancer	0.000744	0.000965	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KRAS—pancreatic cancer	0.000744	0.000965	CbGpPWpGaD
Phenazopyridine—Rash—Doxorubicin—pancreatic cancer	0.000743	0.00325	CcSEcCtD
Phenazopyridine—Dermatitis—Doxorubicin—pancreatic cancer	0.000742	0.00325	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—CTNNB1—pancreatic cancer	0.000739	0.000957	CbGpPWpGaD
Phenazopyridine—Headache—Doxorubicin—pancreatic cancer	0.000738	0.00323	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—MMP9—pancreatic cancer	0.000724	0.000939	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NOTCH1—pancreatic cancer	0.000724	0.000939	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—pancreatic cancer	0.000721	0.000934	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KRAS—pancreatic cancer	0.000718	0.00093	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KRAS—pancreatic cancer	0.000718	0.00093	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KRAS—pancreatic cancer	0.000715	0.000926	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CTNNB1—pancreatic cancer	0.00071	0.00092	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CTNNB1—pancreatic cancer	0.00071	0.00092	CbGpPWpGaD
Phenazopyridine—Nausea—Doxorubicin—pancreatic cancer	0.0007	0.00307	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—SRC—pancreatic cancer	0.000698	0.000905	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP9—pancreatic cancer	0.000696	0.000902	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP9—pancreatic cancer	0.000696	0.000902	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—HRAS—pancreatic cancer	0.000689	0.000892	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CTNNB1—pancreatic cancer	0.000684	0.000887	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CTNNB1—pancreatic cancer	0.000684	0.000887	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PPARG—pancreatic cancer	0.000684	0.000886	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—pancreatic cancer	0.00068	0.000881	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—STAT3—pancreatic cancer	0.000673	0.000873	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NRAS—pancreatic cancer	0.000672	0.00087	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP9—pancreatic cancer	0.000671	0.00087	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP9—pancreatic cancer	0.000671	0.00087	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SRC—pancreatic cancer	0.000668	0.000865	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HRAS—pancreatic cancer	0.000664	0.000861	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP9—pancreatic cancer	0.000661	0.000857	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—HRAS—pancreatic cancer	0.000659	0.000854	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—pancreatic cancer	0.000658	0.000853	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—pancreatic cancer	0.00065	0.000843	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—STAT3—pancreatic cancer	0.000644	0.000835	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NRAS—pancreatic cancer	0.000642	0.000833	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SRC—pancreatic cancer	0.000642	0.000831	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SRC—pancreatic cancer	0.000642	0.000831	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—HRAS—pancreatic cancer	0.000633	0.00082	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—HRAS—pancreatic cancer	0.000633	0.00082	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP2—pancreatic cancer	0.000628	0.000813	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—pancreatic cancer	0.000625	0.00081	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—pancreatic cancer	0.000625	0.00081	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TGFB1—pancreatic cancer	0.000624	0.000809	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—STAT3—pancreatic cancer	0.000619	0.000802	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—STAT3—pancreatic cancer	0.000619	0.000802	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SRC—pancreatic cancer	0.000619	0.000802	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SRC—pancreatic cancer	0.000619	0.000802	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NRAS—pancreatic cancer	0.000617	0.0008	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NRAS—pancreatic cancer	0.000617	0.0008	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—EGFR—pancreatic cancer	0.000612	0.000793	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—HRAS—pancreatic cancer	0.00061	0.000791	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—HRAS—pancreatic cancer	0.00061	0.000791	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SRC—pancreatic cancer	0.000609	0.00079	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HRAS—pancreatic cancer	0.000608	0.000787	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—pancreatic cancer	0.000602	0.000781	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—pancreatic cancer	0.000602	0.000781	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TGFB1—pancreatic cancer	0.000597	0.000774	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—STAT3—pancreatic cancer	0.000597	0.000773	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—STAT3—pancreatic cancer	0.000597	0.000773	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NRAS—pancreatic cancer	0.000595	0.000771	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NRAS—pancreatic cancer	0.000595	0.000771	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—pancreatic cancer	0.000594	0.000769	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—pancreatic cancer	0.000586	0.00076	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—NRAS—pancreatic cancer	0.000586	0.00076	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EGFR—pancreatic cancer	0.000585	0.000759	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—pancreatic cancer	0.000583	0.000755	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KRAS—pancreatic cancer	0.000578	0.000749	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TGFB1—pancreatic cancer	0.000573	0.000743	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TGFB1—pancreatic cancer	0.000573	0.000743	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EGFR—pancreatic cancer	0.000562	0.000729	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EGFR—pancreatic cancer	0.000562	0.000729	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—pancreatic cancer	0.000557	0.000722	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TGFB1—pancreatic cancer	0.000553	0.000717	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TGFB1—pancreatic cancer	0.000553	0.000717	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KRAS—pancreatic cancer	0.000553	0.000717	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EGFR—pancreatic cancer	0.000542	0.000703	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—EGFR—pancreatic cancer	0.000542	0.000703	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—pancreatic cancer	0.000536	0.000695	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—pancreatic cancer	0.000535	0.000694	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—pancreatic cancer	0.000535	0.000694	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—EGFR—pancreatic cancer	0.000534	0.000692	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KRAS—pancreatic cancer	0.000531	0.000688	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KRAS—pancreatic cancer	0.000531	0.000688	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—pancreatic cancer	0.000516	0.000669	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TNF—pancreatic cancer	0.000516	0.000669	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KRAS—pancreatic cancer	0.000512	0.000664	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KRAS—pancreatic cancer	0.000512	0.000664	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KRAS—pancreatic cancer	0.000505	0.000654	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HRAS—pancreatic cancer	0.000491	0.000637	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CTNNB1—pancreatic cancer	0.000481	0.000624	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP9—pancreatic cancer	0.000472	0.000611	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HRAS—pancreatic cancer	0.00047	0.000609	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HRAS—pancreatic cancer	0.000452	0.000585	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HRAS—pancreatic cancer	0.000452	0.000585	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HRAS—pancreatic cancer	0.000435	0.000564	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HRAS—pancreatic cancer	0.000435	0.000564	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SRC—pancreatic cancer	0.000435	0.000564	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—pancreatic cancer	0.000434	0.000562	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—HRAS—pancreatic cancer	0.000429	0.000556	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—pancreatic cancer	0.000424	0.000549	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—STAT3—pancreatic cancer	0.000419	0.000544	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NRAS—pancreatic cancer	0.000418	0.000542	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—pancreatic cancer	0.000415	0.000538	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—pancreatic cancer	0.000399	0.000517	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—pancreatic cancer	0.000399	0.000517	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TGFB1—pancreatic cancer	0.000389	0.000504	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—pancreatic cancer	0.000384	0.000498	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—pancreatic cancer	0.000384	0.000498	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EGFR—pancreatic cancer	0.000381	0.000494	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—pancreatic cancer	0.000363	0.00047	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KRAS—pancreatic cancer	0.00036	0.000467	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HRAS—pancreatic cancer	0.000306	0.000397	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—pancreatic cancer	0.00027	0.00035	CbGpPWpGaD
